Literature DB >> 23322133

Aggregation and chemical modification of monoclonal antibodies under upstream processing conditions.

Stefan Dengl1, Marc Wehmer, Friederike Hesse, Florian Lipsmeier, Oliver Popp, Kurt Lang.   

Abstract

PURPOSE: To investigate antibody stability and formation of modified species under upstream processing conditions.
METHODS: The stability of 11 purified monoclonal human IgG1 and IgG4 antibodies, including an IgG1-based bispecific CrossMab, was compared in downscale mixing stress models. One of these molecules was further evaluated in realistic bioreactor stress models and in cell culture fermentations. Analytical techniques include size exclusion chromatography (SEC), turbidity measurements, cation exchange chromatography (cIEX), dynamic light scattering (DLS) and differential scanning calorimetry (DSC).
RESULTS: Sensitivity in downscale stress models varies among antibodies and results in formation of high molecular weight (HMW) aggregates. Stability is increased in cell culture medium and in bioreactors. Media components stabilizing the proteins were identified. Extensive chemical modifications were detected both in stress models as well as during production of antibodies in cell culture fermentations.
CONCLUSIONS: Protective compounds must be present in chemically defined fermentation media in order to stabilize antibodies against the formation of HMW aggregates. An increase in chemical modifications is detectable in bioreactor stress models and over the course of cell culture fermentations; this increase is dependent on the expression rate, pH, temperature and fermentation time. Consequently, product heterogeneity increases during upstream processing, and this compromises the product quality.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23322133     DOI: 10.1007/s11095-013-0977-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  53 in total

1.  Protein aggregation during overexpression limited by peptide extensions with large net negative charge.

Authors:  Yian-Biao Zhang; Jason Howitt; Sean McCorkle; Paul Lawrence; Karen Springer; Paul Freimuth
Journal:  Protein Expr Purif       Date:  2004-08       Impact factor: 1.650

2.  Culture temperature modulates aggregation of recombinant antibody in cho cells.

Authors:  Natalia Gomez; Jayashree Subramanian; Jun Ouyang; Mary D H Nguyen; Matthew Hutchinson; Vikas K Sharma; Andy A Lin; Inn H Yuk
Journal:  Biotechnol Bioeng       Date:  2011-10-03       Impact factor: 4.530

Review 3.  Effects of shear on proteins in solution.

Authors:  C R Thomas; D Geer
Journal:  Biotechnol Lett       Date:  2010-11-18       Impact factor: 2.461

4.  Engineering aggregation resistance in IgG by two independent mechanisms: lessons from comparison of Pichia pastoris and mammalian cell expression.

Authors:  Jonas V Schaefer; Andreas Plückthun
Journal:  J Mol Biol       Date:  2012-01-27       Impact factor: 5.469

Review 5.  Antibody structure, instability, and formulation.

Authors:  Wei Wang; Satish Singh; David L Zeng; Kevin King; Sandeep Nema
Journal:  J Pharm Sci       Date:  2007-01       Impact factor: 3.534

Review 6.  Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods.

Authors:  J Vlasak; R Ionescu
Journal:  Curr Pharm Biotechnol       Date:  2008-12       Impact factor: 2.837

7.  Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization.

Authors:  S Li; C Schöneich; R T Borchardt
Journal:  Biotechnol Bioeng       Date:  1995-12-05       Impact factor: 4.530

8.  'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization.

Authors:  J B Ridgway; L G Presta; P Carter
Journal:  Protein Eng       Date:  1996-07

9.  Aggregation stability of a monoclonal antibody during downstream processing.

Authors:  Paolo Arosio; Giuliano Barolo; Thomas Müller-Späth; Hua Wu; Massimo Morbidelli
Journal:  Pharm Res       Date:  2011-03-30       Impact factor: 4.200

10.  High-throughput measurement, correlation analysis, and machine-learning predictions for pH and thermal stabilities of Pfizer-generated antibodies.

Authors:  Amy C King; Matthew Woods; Wei Liu; Zhijian Lu; Davinder Gill; Mark R H Krebs
Journal:  Protein Sci       Date:  2011-07-13       Impact factor: 6.725

View more
  7 in total

1.  Future of sustained protein delivery.

Authors:  Ravi Vaishya; Ashim K Mitra
Journal:  Ther Deliv       Date:  2014-11

2.  Direct analysis of mAb aggregates in mammalian cell culture supernatant.

Authors:  Albert J Paul; Karen Schwab; Friedemann Hesse
Journal:  BMC Biotechnol       Date:  2014-11-29       Impact factor: 2.563

Review 3.  Main Quality Attributes of Monoclonal Antibodies and Effect of Cell Culture Components

Authors:  Fatemeh Torkashvand; Behrouz Vaziri
Journal:  Iran Biomed J       Date:  2017-04-20

Review 4.  The use of CrossMAb technology for the generation of bi- and multispecific antibodies.

Authors:  Christian Klein; Wolfgang Schaefer; Jörg T Regula
Journal:  MAbs       Date:  2016-06-10       Impact factor: 5.857

5.  AlphaScreen-based homogeneous assay using a pair of 25-residue artificial proteins for high-throughput analysis of non-native IgG.

Authors:  Yukako Senga; Hiroshi Imamura; Takamitsu Miyafusa; Hideki Watanabe; Shinya Honda
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

6.  Evaluation of fluorescent dyes to measure protein aggregation within mammalian cell culture supernatants.

Authors:  Sheun Oshinbolu; Rachana Shah; Gary Finka; Mike Molloy; Mark Uden; Daniel G Bracewell
Journal:  J Chem Technol Biotechnol       Date:  2018-01-05       Impact factor: 3.174

7.  Mitigation of liquid-liquid phase separation of a monoclonal antibody by mutations of negative charges on the Fab surface.

Authors:  Tatsuji Matsuoka; Ryuki Miyauchi; Nobumi Nagaoka; Jun Hasegawa
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.